Related Experiment Video

Updated: May 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Temporal Trends in Lipid-Lowering Therapy Use and Adherence in Patients With Premature Coronary Artery Disease

Diana N Vikulova1, Danielle Pinheiro-Muller2, Simon N Pimstone1,3

  • 1Department of Medicine University of British Columbia Vancouver Canada.

Journal of the American Heart Association
|May 6, 2026
PubMed

Insights

Improving lipid-lowering therapy (LLT) adherence in premature coronary artery disease (CAD) is crucial. While short-term adherence and high-intensity LLT use have increased, long-term adherence requires better strategies to prevent recurrent cardiovascular events.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Premature coronary artery disease (CAD) is associated with high rates of recurrent events and mortality.
  • Limited data exists on long-term adherence to lipid-lowering therapy (LLT) and medication-taking behaviors in this population.
  • Understanding adherence trends and their impact is vital for improving patient outcomes.

Purpose of the Study:

  • To assess temporal trends in LLT use and adherence in patients with premature CAD.
  • To identify factors associated with adherence to LLT.
  • To evaluate the consequences of low LLT adherence on cardiovascular outcomes.

Main Methods:

  • Analysis of a cardiovascular registry and administrative databases from 2000 to 2017.
  • Inclusion of 11,411 patients with premature obstructive CAD.
  • Assessment of temporal changes in LLT adherence rates, predictors, and association with cardiovascular outcomes.

Main Results:

  • Good first-year LLT adherence increased from 54.9% to 71.4% (P<0.001), while third-year adherence showed smaller gains (44.4% to 47.3%; P<0.001).
  • High-intensity LLT use rose significantly from 26.7% to 92.0% (P<0.001).
  • Good adherence was linked to reduced risks of death (HR, 0.45) and myocardial infarction (HR, 0.53). Factors like severe presentation and non-smoking predicted better adherence, while rural residence and female sex were linked to poorer adherence in later years.

Conclusions:

  • While short-term LLT adherence and high-intensity LLT use are improving in premature CAD, long-term adherence remains a challenge.
  • Targeted strategies are necessary to enhance long-term LLT adherence.
  • Improved long-term adherence is essential for preventing recurrent cardiovascular events in patients with premature CAD.
Abstract

Keywords:
adherence to lipid‐lowering therapycardiovascular outcomespredictors of adherencepremature coronary artery diseasetemporal trends

More Related Videos

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

749

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659